Sugi Predict

Sugi Predict / Compounds / SCHEMBL2126087

SCHEMBL2126087

SCHEMBL2126087

CCCCC/C=C\C/C=C\CCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCCCCC/C=C\C/C=C\CCCCC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.76
▸ MEN1 O00255 2/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ AKT1 P31749 2/20 0.69
▸ LMNA P02545 2/20 0.69
▸ PRKD3 O94806 1/20 0.69
▸ PRKCG P05129 1/20 0.69
▸ PRKCB P05771 1/20 0.69
▸ PRKCA P17252 1/20 0.69
▸ PRKCH P24723 1/20 0.69
▸ PRKCI P41743 1/20 0.69
▸ PRKCE Q02156 1/20 0.69
▸ PRKCQ Q04759 1/20 0.69
▸ PRKCZ Q05513 1/20 0.69
▸ PRKCD Q05655 1/20 0.69
▸ PRKD1 Q15139 1/20 0.69
▸ MAPK1 P28482 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ GMNN O75496 1/20 0.69
▸ BLM P54132 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203174 1.00 ALDH1A1 (0.76) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL7558240 1.00 ALDH1A1 (0.76) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL29733465 0.99 ALDH1A1 (0.74) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL29394546 0.97 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL53200 0.97 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL29365750 0.97 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL29905581 0.97 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL94022 0.90 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL93475 0.90 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AAKT1LMNA
SCHEMBL1532761 0.90 AKT1 (0.83) ALDH1A1MEN1KMT2AAKT1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025052180-A2 LIPIDS AND LIPID NANOPARTICLES Axelyf ehf. (IS) 2025-03-13 — — WO claimed
WO-2023236824-A1 DENDRON-LIKE LIPID COMPOUND, LIPOSOME, LIPID COMPLEX, AND LIPID NANOPARTICLE AND USE THEREOF 中国科学院广州生物医药与健康研究院 2023-12-14 — — WO claimed
WO-2023232147-A1 AMINO ACID CATIONIC LIPID 厦门赛诺邦格生物科技股份有限公司 2023-12-07 — — WO claimed
WO-2023198084-A1 NITROGEN-BRANCHED NONLINEAR PEGYLATED LIPID AND USE THEREOF 厦门赛诺邦格生物科技股份有限公司 2023-10-19 — — WO claimed
US-20250108007-A1 LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2025-04-03 — — US disclosed
EP-4424670-A1 LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION Suzhou Abogen Biosciences Co., Ltd. (CN) 2024-09-04 — — EP disclosed
EP-2444464-A1 Novel neutral (bio)material Centre National de la Recherche Scientifique (CNRS) (FR) 2012-04-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250108007-A1 LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION CETP, NPC1, LCAT ALDH1A1 2886/4885MEN1 1956/4885KMT2A 1102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.